Mandatories.

ULTHERAPY

The non-invasive Ultherapy® procedure is indicated for dermatological sculpting and lifting of the dermis on the upper face, lower face, neck, and décolletage though the deposition of micro-focused ultrasound energy. Ultherapy® should not be used on persons with open wounds, lesions, severe or cystic acne, or implants in the treated area. THIS PRODUCT IS NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC. Always read the label and consult your Healthcare Professional for more information. This medical device must be administered by a Healthcare Professional or trained personnel, under the supervision of a physician. If you are a Healthcare Professional, please review the Ultherapy® Instructions for Use before administering treatment, available from https://www.merzaustralia.com.au/products/

PROFHILO® STRUCTURA

Is a class 3 medical device and must be injected by a medical practitioner or a qualified nurse injector (operating under the supervision of a medical practitioner).PROFHILO® STRUCTURA [4.5% – 22.5 mg (H-HA) + 22.5 mg (L-HA)/1 ml Hyaluronic acid sodium salt and 4.5% – 45 mg (H-HA) + 45 mg (L-HA)/2 ml Hyaluronic acid sodium salt], injection gel in a single use sterile prefilled syringe. It is indicated for adults of both sexes for corrective / filling action of natural or induced skin depressions. PROFHILO® STRUCTURA has risks and benefits. Ask your healthcare professional if PROFHILO® STRUCTURA is right for you and to explain the possible side effects. WARNINGS & PRECAUTIONS: Do not use PROFHILO® STRUCTURA in case of known hypersensitivity or allergies to the components of the product. Do not use it in pregnant or breast-feeding women, in patients with autoimmune diseases. Do not inject intravascularly, into the muscles or tendons, or for breast enlargement. CONTRAINDICATIONS: PROFHILO® STRUCTURA must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. Tell your doctor if any side effects concern you.ALWAYS FOLLOW THE INSTRUCTIONS YOU ARE GIVEN. Treatment costs and normal practitioner fees will apply. Please contact us for any further information or for the IFU (Instructions for use) of this product or for medical information or reporting any adverse effects. Distributed in New Zealand by Dermocosmètica (NZBN 9429050049066) Suite A, Floor 8 Harbourview Building, 152 Quay St, Auckland Central,Auckland, New Zealand, through Healthcare Logistics, 58 Richard Pearse Drive, Airport Oaks, Manukau City, Auckland, New Zealand.

PROFHILO®

Containing low & high molecular weight hyaluronic acid, is a Class III medical device for the treatment of the face and body for contours redefinition and laxity remodelling where skin laxity is a problem. Profhilo has risks and benefits. Do not use with treatments such a laser resurfacing or medium deep skin-peeling. Caution in people on blood thinning medicines.Do not inject into inflamed areas or intravenously or intramuscularly. Possible side effects: pain and swelling at injection site. Distributed in New Zealand by Dermocosmètica (NZBN 9429050049066) Suite A, Floor 8 Harbourview Building, 152 Quay St, Auckland Central,Auckland, New Zealand, through Healthcare Logistics, 58 Richard Pearse Drive, Airport Oaks, Manukau City, Auckland, New Zealand.

BOTOX®

Is a prescription medicine containing 100 units of clostridium botulinum type A toxin complex for injection. It is used for the treatment of severe frown lines associated 'crow's feet' around the eyes and wrinkle removal. It should be administered only by trained medical professionals. Talk to your specialists about the benefits/risks of this procedure in appearance medicine. Caution people with neuromuscular transmission disorders, presence of infection at site of injection, pregnancy and lactation. Possible side effects include headaches, pain, burning sensation or redness at injection site, temporary local muscle weakness including eyelid droop, decreased sensation and nausea. If you have side effects or concerns, talk to your doctor. A charge applies. Allergan New Zealand Pty Ltd, Auckland. Note: Botox® treatment lasts about four months and after this time further courses of Botox treatment may be necessary. Talk to your Botox specialist about the benefits/risks of this procedure.

DYSPORT®

Is a prescription medicine for the treatment of frown lines, horizontal forehead lines and crow’s fee round the eyes. Dysport® has risks and benefits. Ask your doctor is Dysport® is right for you. If you have side effects see your doctor. You will need to pay for Dysport®, and clinic fees will apply. For details on precautions & side effects consult your healthcare professional or the Consumer Medicine Information (CMI) at www.medsafe.govt.nz. Dysport® lasts about 4-6 months and further courses of treatment may be necessary. Should only be administered by trained medical professionals. Contains 500 units of clostridium botulinum Type A toxin. Galderma (NZ) Limited, Auckland.

XEOMIN®

(Incobotulinumtoxin A) 50, 100 Units is a Prescription Medicine. Indications: In adults for the treatment of cervical dystonia; blepharospasm; spasticity of the upper limb; upper facial lines: glabellar from lines, lateral periorbital lines (crows feet), horizontal forehead lines. Xeomin® has both risks and benefits, consults your doctor if Xeomin® is right for you. Further information on the risks and benefits of Xeomin® can be found in the Consumer Medicine Information (CMI) available from www. medsafe.govt.nz or by calling 0800 822 310. Use strictly as directed. If symptoms continue or you have side effects, see your doctor, pharmacist or health care professional. Common side effects include: Headaches; nausea; tenderness, swelling, redness, numbness or bruising of the skin; dry eye; heavy feeling or eyelid/eyebrow/forehead; face/brow not symmetrical. dropping eyelids/eyebrows. Serious side effects are rare and include allergic reactions. XOEMIN® is an unfunded medicine, prescription charge will apply. Normal doctor charges will still apply. Medical information: Ph 0800 822 310. Copyright 2021. Pharmacy Retailing NZ Limited t/a Health Care Logistics (HCL) 58 Richard Pearse Drive, Mangere, Auckland 2022. All rights reserved. Xeomin® and Merz Aesthetics are registered trademarks of Merz Pharma MGMbH & Co.

SUNEKOS

Sunekos 1200 is an implantable medical device that modifies the structure of mature skin, restoring volume, filling wrinkles and folds in the skin and in scar sites. It is suitable for creating a temporary increase in the volume of skin tissue. Sunekos 1200 is a medical device that is sterile, injectable, non-pyrogenic, biocompatible, re-absorbable, made with hyaluronic acid and amino acids. Sunekos Performa is a medical device recommended for the treatment of blemishes and depressions in the skin caused by wrinkles and scars. Sunekos Performa is a sterile resorbable injectable solution which acts as a filler, supporting the restoration of physiological elasticity and temporarily replacing volume by expanding the soft tissues. Sunekos should not be used on patients: with known hypersensitivity to any of its components; presenting with a general infection, inflammatory or infectious cutaneous problems; with history of severe multiple allergies or anaphylactic shock; prone to hypertrophic scars/keloids or streptococcal diseases; in patients presenting with porphyria; under 18 years of age; in pregnancy or lactation; others. See full Instructions for use before prescribing for full safety information, available from www.xytide.co.nz Copyright© 2024. Xytide Biotech Pty Ltd. Always read the label and follow the instructions. This medical device must be administered by a Healthcare Professional. New Zealand Sponsor: AA-Med Pty Ltd Distributed by: Xytide Biotech NZ Pty Ltd (NZBN 9429049668612) C/O Alliott Ltd, Level 2, 142 Broadway, Newmarket, Auckland 1023 NZ. For more information please phone +61 1800 570 036 *Pilot study evaluating the therapeutic effects of a new pre-mixed injectable product of low molecular weight (LMW) hyaluronic acid added to six amino acids (HY6AA +Formula) in facial skin aging. - Fasola E, Kutera E. J Dermat Cosmetol. 2022;6(3):74-77 **Assessing the Rejuvenation Effectiveness of a Hyaluronic Acid and Amino Acid Mixture in the Periorbital Region - Kabakci AG, Bozkır DM, Cengizler Ç, Sire Eren D, Bozkır MG. Clin Cosmet Investig Dermatol. 2023 Apr 6;16:973-980

RESTYLANE®

Is a gel containing hyaluronic acid and lidocaine that is injected by a healthcare professional into or below the skin to smooth facial wrinkles and enhance lips by restoring volume and fullness. Restylane is a Class III medical device and has risks and benefits. Restylane® treatment may result in some redness, swelling, pain or tenderness, itching and/or bruising which may last a few days. Inflammatory reactions can begin up to two to four weeks after treatment in rare cases. See your healthcare professional if any side effects concern you. Exposure to excessive sunlight or extreme cold should be avoided until redness or swelling has resolved. Restylane® should not be used in an area where there is a nonresorbable implant or in irritated or infected skin, Restylane® should not be used in people taking blood thinning medicines or who have an allergy to hyaluronic acid, lidocaine or other local anaesthetics. Caution if you take medicines that prolong bleeding time. Treatment lasts 12-24 months. Restylane has not been tested in pregnant or breast-feeding women. ALWAYS FOLLOW THE INSTRUCTIONS YOU ARE GIVEN. Galderma, Auckland. Distributed by Healthcare Logistics, Auckland 4. Restylane® Skinboosters is a gel containing hyaluronic acid th

TEOSYAL (PURESENSE) REDENSITY (I)

TEOSYAL Redensity [I]® is a product of the TEOSYAL®PureSense range (medical devices, class III, CE mark) for medical professional use only. This medical device is indicated for the prevention of wrinkles, rehydratation of the face, neck and neckline. 15mg/ml of HA with a "dermo-restructuring complex" of 8 amino acids (Glycine, Lysine, Threonine, Proline, Isoleucine, Leucine, Valine and Arginine), 3 antioxidants (Glutathion, N-acetyl-L-cysteine and Alphalipoic Acid), vitamin B6 and minerals (Zinc and Copper) with lidocaine, 2 x 1ml syringes per box. Redensity I is a light reflecting product positioned between the meso product and the dermal fillers. Treatment consists of preforming micro-injections of Redensity I across the skin so that the dermo-restructuring complex is spread evenly. The manufacturers recommend 3 treatments at 3 weekly intervals. Distributed by Mondeal Aesthetics Australia.

RESTYLANE® SKINBOOSTERS

Is a gel containing hyaluronic acid that is injected into or below the skin to improve skin structure, hydration and elasticity. Restylane® Skinboosters is a medical device class III that has risks and benefits. Do not use in patients with bleeding disorders, or in patients taking blood thinning medicines. Do not inject intravascularly, where there is active disease, inflammation, infection, or tumours near the intended treatment site Possible side effects are injection site effects like swelling ,bruising and tenderness and inflammation. Treatment usually lasts 6-12 months. Product and treatment costs will apply. Consult your cosmetic practitioner for further information. Further product details can also be found in the full product information. Galderma, Auckland.

SCULPTRA®

Is a poly-L-lactic acid implant liquid that is injected by a healthcare professional into or below the skin to increase volume of depressed areas, particularly to correct skin depressions. Class III Medical Device. Sculptra® may also be used for large volume restoration and/or correction of the signs of facial fat loss. Sculptra has risks and benefits. Sculptra® treatment may result in injection site reactions and pain. Ask your healthcare professional to explain the range of possible side effects and tell them if any side effects concern you. Sculptra® should not be injected into skin that is inflamed or infected. Exposure to excessive sunlight or UV lamp exposure should be avoided until redness or swelling has resolved. Sculptra® is not recommended for people taking blood thinning medicines and has not been tested in pregnant or breast-feeding women or those aged under 18 years. Lasts for 12-25 months ALWAYS FOLLOW THE INSTRUCTIONS YOU ARE GIVEN. Galderma Australia, Sydney. Distributed by Healthcare Logistics Auckland.

DEOXYCHOLIC ACID

Injection is a prescription medicine containing 10 mg/mL deoxycholic acid. It is used for the improvement in the appearance of moderate to severe convexity or fullness associated with fat below the jaws in adults. Do not use in people allergic to this medicine, with infection at site of injection, pregnancy, and lactation. Possible side effects include headaches, difficulty swallowing, nausea, skin tightness, hypertension, injection site bruising /pain /swelling/ numbness/ redness/ tingling/ hardness/ itching / discolouration/ formation of small areas of hardness/ warmth and injection site nerve injury. Deoxycholic Acid treatment is not funded on the New Zealand Pharmaceutical Schedule. You will need to pay for this medicine. Normal Doctors visit fees apply. Deoxycholic Acid injection treatment should be administered only by trained medical professionals. Speak to your specialist about your own situation and about the benefits/risks of this procedure in appearance medicine. For further information, the Data Sheet and Consumer Medicines Information can be accessed at www.medsafe.govt.nz or ask your doctor. If you have any side effects or concerns speak to your doctor. Note: Results from Deoxycholic Acid treatment usually last up to 4 years.

Skin Rejuvenation Clinic Special Full Face IPL Normally $299 now $250

Get glowing for
Valentines Day
with our special offer
on IPL skin treatment!